November 20, 2025
OXFORD, UK and CLEVELAND, Ohio, US, 20 November 2025 – The Oxford-Harrington Rare Disease Centre (‘OHC’) today announced the recipients of the 2025 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice. Each Scholar will receive an advisory team providing...
Continue Reading
April 29, 2025
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation Continue Reading
April 16, 2025
Unique program for physician-scientists to advance promising discoveries into medicines Continue Reading
March 19, 2025
2025 Harrington Prize for Innovation in Medicine recognizes groundbreaking contributions in the creation of targeted cancer therapies Continue Reading
February 18, 2025
Renowned US Neuroscientist and Harvard Professor brings extensive expertise in academia and industry to advance rare disease research Continue Reading
February 05, 2025
Award highlights collaboration between for profit and non-profit achieving great impact Continue Reading
January 27, 2025
At 18 weeks pregnant, Lindsey learned her baby had severe spina bifida. She joined UC Davis’s groundbreaking CuRe Trial combining fetal surgery and stem cells. Over a year later, her son is thriving. Continue Reading
January 15, 2025
Scholar Award Accelerates Novel Therapies for Rare Diseases Continue Reading
December 11, 2024
An off-the-shelf drug shows promise as a low-cost topical treatment for psoriasis. New findings highlight benzamil’s potential to reduce inflammation and skin cell overgrowth without steroids or immune suppression. Continue Reading
December 03, 2024
Inherited SP-B deficiency is an ultra-rare monogenic cause of fatal respiratory distress syndrome in newborn infants with few, if any, options for long-term survival Continue Reading